Recipharm
Stockholm, Sweden
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (11)
○ EMA GMP
○ MHRA GMP
Quick Facts: Recipharm
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Stockholm, Sweden
- Modalities
- Semi-solid drug product (creams, ointments, gels), Sterile fill-finish, Oral solid dose, Biologics
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Recipharm
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSemi-solid drug product (creams, ointments, gels), Sterile fill-finish, Oral solid dose, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (4 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press11 articles
Broad modality coverage (4 modalities)
Recent News 11 articles
Change at the top at Recipharm as strategy shifts - pharmaphorum
Recipharm focuses footprint with sale of Israel API plant, new CDMO partnership - Fierce Pharma
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration - PR Newswire
Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm - PR Newswire
Recipharm makes major investment to expand US sterile manufacturing footprint - European Pharmaceutical Review
Recipharm channels ‘multi-million-dollar' US manufacturing upgrade, targeting domestic biologics demand - Fierce Pharma
Recipharm and Exela Pharma Sciences Form Exclusive CDMO Strategic Alliance - Genetic Engineering and Biotechnology News
Recipharm bolsters fill/finish capacity at German site - BioProcess International
LGC opens $72M chemical plant; Recipharm partners with NeuroSense - Endpoints News
Responding to tougher FDA standards, Recipharm debuts new facility for beta-lactam drugs - Fierce Pharma
Recipharm shutters Boxborough facility, cuts local workforce 40% - Worcester Business Journal
Recipharm shutters Boxborough facility, cuts local workforce 40% Worcester Business Journal
Frequently Asked Questions About Recipharm
What is Recipharm's CDMO Signal Score?
Recipharm has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Recipharm for a manufacturing program?
Use the free AI matchmaker to compare Recipharm against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
PCI Pharma Services
Philadelphia, PA
Sterile fill-finish, Prefilled syringes, Cartridges, Vials, Lyophilization, ADC fill-finish, HPAPI, mRNA, Biologics, Oligonucleotides, Peptides
Famar
Athens, Greece (European operations across multiple sites)
Semi-solid drug product (creams, ointments, gels), Oral solid dose, Sterile injectables, Non-sterile liquids
Pfizer CentreOne
Kalamazoo, MI · McPherson, KS
Signal Score: 91.5
Biologics, mRNA
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 85.6
Oligonucleotide, Biologics, AAV
Lotte Biologics
Incheon, KR · Syracuse, NY
Signal Score: 83.7
Biologics, AAV